Supplemental material
Journal of Medical Economics
Volume 26, 2023 - Issue 1
Open access
1,523
Views
0
CrossRef citations to date
0
Altmetric
Urology
Development of a health economic model to evaluate the cost-effectiveness of roxadustat in treating anemia associated with non-dialysis-dependent chronic kidney disease
Maria Mata Lorenzoa Astellas Pharma Europe Ltd, Addlestone, UKView further author information
, Mahmood Alia Astellas Pharma Europe Ltd, Addlestone, UKCorrespondence[email protected]
https://orcid.org/0000-0003-3099-1776View further author information
Stuart Mealingb York Health Economics Consortium, University of York, York, UK
https://orcid.org/0000-0002-2564-1440View further author information
Joe Mossb York Health Economics Consortium, University of York, York, UK
https://orcid.org/0000-0002-1866-9752View further author information
Pages 1250-1260
|
Received 26 Apr 2023, Accepted 22 Sep 2023, Published online: 10 Oct 2023
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.